Abstracts tagged "fibromyalgia"

Abstract Number: 448 • 2019 ACR/ARP Annual Meeting
Central Sensitization in Patients with Rheumatoid Arthritis Using the Central Sensitization Inventory
Kentaro Noda¹, Moe Saitou ¹, Taro Ukichi ¹, Yohsuke Oto ¹, Ken Yoshida ¹ and Daitaro Kurosaka ¹, ¹The Jikei University School of Medicine, Tokyo, Japan
Background/Purpose: Pain of rheumatoid arthritis (RA) is thought to be nociceptive. However, recent studies indicate that RA pain also includes the mechanism of central sensitization…
Abstract Number: 219 • 2019 ACR/ARP Annual Meeting
A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI
Theodore Pincus¹, Isabel Castrejon ² and Joel Block ², ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Fibromyalgia (FM) generally is easily recognized, but a diagnosis may be difficult, particularly in patients with secondary FM who have other primary diagnoses. Criteria…
Abstract Number: 683 • 2019 ACR/ARP Annual Meeting
Biologic Differences Between Type 1 and 2 Lupus
Megan Clowse¹, Jennifer Rogers ¹, Amanda Eudy ¹, Lisa Criscione-Schreiber ¹, Jayanth Doss ¹, Rebecca Sadun ¹, Kai Sun ¹, Micah McClain ², Ephraim Tsalik ³, Chris Woods ², David Pisetsky ⁴, Prathyusha Bachali ⁵, Amrie Grammer ⁶, Michelle Catalina ⁵ and Peter Lipsky ⁷, ¹Duke University, Durham, ²Duke University & Duke Center for Applied Genomics & Precision Medicine, Durham, ³Duke University, Duke Center for Applied Genomics & Precision Medicine, Durham VA, Durham, ⁴Duke University, Durham VAMC, Durham, ⁵AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, VA, ⁶AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, ⁷AMPEL BioSolutions, LLC, Charlottesville, VA
Background/Purpose: The manifestations of systemic lupus erythematosus (SLE) can be divided into categories according to a recently proposed model: a category of classic active autoimmune-driven…
Abstract Number: 220 • 2019 ACR/ARP Annual Meeting
A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia
Raveendhara Bannuru¹, Michelle Park ², Lori Lyn Price ³ and Chenchen Wang ⁴, ¹Tufts Medical Center, Boston, MA, ²Tufts University School of Medicine, Boston, MA, ³Tufts Medical Center, Tufts University, Boston, MA, ⁴Tufts Medical Center, Boston
Background/Purpose: Identifying the factors associated with response to nonpharmacological therapies in patients with fibromyalgia will help personalize treatments and provide information to improve the design…
Abstract Number: 827 • 2019 ACR/ARP Annual Meeting
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia (FM): Evidence for a Broad Spectrum of Activity on the FM Syndrome
Gregory Sullivan¹, R. Michael Gendreau ², Judith Gendreau ³, Ashild Peters ⁴, Perry Peters ⁵ and Seth Lederman ⁶, ¹Tonix Pharmaceuticals Inc., New York, ²Gendreau Consulting, Poway, CA, ³Tonix Pharmaceuticals Inc, Poway, CA, ⁴Tonix Pharmaceuticals Inc., San Diego, CA, ⁵Tonix Pharmaceuticals Inc, San Diego, CA, ⁶Tonix Pharmaceuticals Inc, New York, NY
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain, unrefreshing sleep, fatigue, and cognitive complaints. TNX-102 SL* is a sublingual (SL) formulation of cyclobenzaprine (CBP)…
Abstract Number: 223 • 2019 ACR/ARP Annual Meeting
Correlation Between Heart Rate Variability Parameters and Circulating Neuropeptides in Fibromyalgia
Laura Aline Martínez-Martínez¹, Claudia Lerma Gonzalez ², María del Carmen Navarro Gonzalez ³, Oscar Infante Vázquez ⁴, Felipe Israel López Trejo ⁵, Evelyn Aranda Cano ⁵, Alfonso Salgado Aguayo ³, Daniel Paz Gómez ³, María Isabel Barrera Villalpando ⁶, Luis Silveira ⁷, Violeta Higuera Ortiz ⁸, Angélica Vargas Guerrero ⁵ and Manuel Martínez-Lavín ⁹, ¹Departamento de Reumatologia del Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ²Departamento de Instrumentación del Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, ³Laboratorio de Investigación en Enfermedades Reumáticas del Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico, ⁴Departamento de Instrumentación del Instituto Nacional de Cardiología Ignacio Chávez, Mexico Ciity, Mexico, ⁵Departamento de Reumatología del Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, ⁶Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico, ⁷Departamento de Reumatología, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, México., Mexico, Mexico, ⁸Hospital General de Zona y Medicina Familiar 8 del Instituto Mexicano del Seguro Social, Mexico City, Mexico, ⁹Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
Background/Purpose: Heart rate variability analyses in fibromyalgia patients have shown changes consistent with sympathetic hyperactivity that theoretically could lead to chronic pain. There is little…
Abstract Number: 828 • 2019 ACR/ARP Annual Meeting
A Path Model Analysis of the Cognitive Determinants of Physical Activity Among Patients with Fibromyalgia (FM)
Dennis Ang ¹, Anthony Kaleth ² and William Bush³, ¹Wake Forest School of Medicine, Winston Salem, ²Indiana University-Purdue University Indianapolis, IN, Indianapolis, IN, ³Wake Forest Baptist Medical Center, Winston-Salem, NC
Background/Purpose: In individuals with FM, regular participation in physical activity (PA) is associated with improvement of symptoms, daily physical functioning, and overall well-being. Given the…
Abstract Number: 224 • 2019 ACR/ARP Annual Meeting
A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients with Fibromyalgia: A Randomized Controllel Trial
Giovana Fernandes¹, Fabio Jennings ¹, Michele Nery ¹, Rebeka Santos ¹ and Jamil Natour ¹, ¹Federal University of São Paulo, São Paulo, Brazil
Background/Purpose: Fibromyalgia (FM) is a syndrome characterized mainly by chronic generalized pain that affects the physical fitness and functional capacity of patients. There is increasing…
Abstract Number: 829 • 2019 ACR/ARP Annual Meeting
Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia
Amir minerbi¹, Stéphanie Chevalier ², Abraham Anjarkouchian ², Audrey Moyen ², Yoram Shir ¹ and Mary-Ann Fitzcharles ¹, ¹Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada, ²School of Human Nutrition, McGill University, Montreal, Canada
Background/Purpose: We have recently reported significant alterations in gut microbiome compositionin women with fibromyalgia (FM). As gut microbiome is affected by diet, differences in nutritional…
Abstract Number: 225 • 2019 ACR/ARP Annual Meeting
Evaluating Fibromyalgia Symptoms in Transgender Patients
Dana Levit¹, Jacob Ablin ¹, Valerie Aloush ¹ and Iris Yaish ¹, ¹Tel Aviv Sourasky medical center, Tel Aviv, Israel
Background/Purpose: Fibromyalgia Syndrome (FMS), characterized by widespread pain and fatigue, is known to be more prevalent in women, and has frequently been associated with stress…
Abstract Number: 830 • 2019 ACR/ARP Annual Meeting
The Efficacy of Non-Pharmacological Interventions for Fibromyalgia: A Systematic Review with Meta-Analysis
Burak Kundakci¹, Jaspreet Kaur ², Siew-Li Goh ³, Michelle Hall ⁴, Michael Doherty ⁵, Weiya Zhang ⁵ and Abhishek Abhishek ⁶, ¹Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/Arthritis Research UK Pain Centre, Nottingham, UK, Nottingham, United Kingdom, ²Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK, Nottingham, United Kingdom, ³Sports Medicine Unit, University of Malaya, Kuala Lumpur, Malaysia, Kuala Lumpur, Malaysia, ⁴Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/Arthritis Research UK Pain Centre, Nottingham, UK/National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK/Division of Physiotherapy and Rehabilitation Sciences, University of Nottingham, Nottingham, UK, Nottingham, United Kingdom, ⁵Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/Arthritis Research UK Pain Centre, Nottingham, UK/National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK, Nottingham, United Kingdom, ⁶Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK, Nottingham, United Kingdom
Background/Purpose: Non-pharmacological interventions are recommended as first-line treatment for fibromyalgia (FM)1. However, the evidence base supporting this has not been updated comprehensively, and the recent…
Abstract Number: 226 • 2019 ACR/ARP Annual Meeting
Hypersensitivity Beyond Pain: Hyperacusis and Hyperalgesia of Patients with Fibromyalgia
Roland Staud ¹, Gabriella Tom¹, Melyssa Godfrey ¹ and Michael Robinson ¹, ¹University of Florida, Gainesville, FL
Background/Purpose: Fibromyalgia (FM) is a condition in which patients are afflicted with unexplained chronic musculoskeletal pain, insomnia and fatigue. The underlying mechanisms of this disorder…
Abstract Number: 831 • 2019 ACR/ARP Annual Meeting
Maintaining Musculoskeletal Health: A Randomized Controlled Prevention Trial Amongst People at High Risk of Developing Chronic Widespread Pain
Gary Macfarlane¹, Marcus Beasley ¹, Neil Scott ¹, Gordon Prescott ², Paul McNamee ¹, John McBeth ³, Gareth Jones ¹, Neil Basu ⁴, Phil Hannaford ¹, Phil Keeley ⁵ and Karina Lovell ⁶, ¹University of Aberdeen, Aberdeen, United Kingdom, ²University of Central Lancashire, Preston, United Kingdom, ³Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, ⁴University of Glasgow, Glasgow, United Kingdom, ⁵University of Huddersfield, Huddersfield, United Kingdom, ⁶University of Manchester, Manchester, United Kingdom
Background/Purpose: Cognitive behaviour therapy (CBT) is effective in the management of fibromyalgia (and its characteristic feature Chronic Widespread Pain (CWP). CBT is recommended in all…
Abstract Number: 227 • 2019 ACR/ARP Annual Meeting
Metabolomic and Symptom Comparison in Women With/without Fibromyalgia: A Pilot Study
Victoria Menzies¹, Angela Starkweather ², Yingwei Yao ³, Timothy Garrett ⁴, Debra Lynch-Kelly ³, Param Patel ² and Debra E. Lyon ³, ¹Virginia Commonwealth University School of Nursing, Richmond, VA, ²University of Connecticut School of Nursing, Storrs, CT, ³College of Nursing, University of Florida, Gainesville, FL, ⁴Southeast Center for Integrated Metabolomics, University of Florida, Gainesville, FL
Background/Purpose: The biological perturbations associated with fibromyalgia (FM) remain unclear. The recognition of objective measures to confirm FM diagnosis have not been identified. The obscurity…
Abstract Number: 1195 • 2019 ACR/ARP Annual Meeting
Quantitative Physician Global Assessment of Damage And/or Distress, in Addition to Inflammation, at Routine Rheumatology Care: Documenting the Complexity of Rheumatology Patient Encounters as a Rationale for Possible Higher Reimbursement?
Theodore Pincus¹, Isabel Castrejon ² and Joel A. Block ², ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Quantitative clinical measures and indices such as DAS28, CDAI, SLEDAI, BASDAI, are designed to assess inflammation, reflecting a goal to prevent long-term damage, and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].